evidence-based science

Economists urge support for India's GMO mustard

The opponents to commercialization criticize the regulatory process. The integrity of the regulatory process is paramount and it should be protected at all costs. Products that meet the benchmarks laid down by a fair, transparent and rigorous regulatory process should be approved for commercialization. However, it is self-defeating to test indefinitely without end. That amounts to a ban on commercialization of all GM crops. That may serve the critics of GM crops.​ But surely that is not the intent of the government of India. Foregoing yield increases is very costly – especially to the poor.

"Food Evolution" – the ever evolving science

Biotechnology has huge potential, does not belong to corporations, and delaying it further will only serve to hurt all farmers, big and small, and people in general. Today the big challenge is how to address issues like climate change and food security. If, for example, biotechnology can contribute to mitigating climate change, we need to talk about how to use and regulate it effectively. It's true, biotechnology has a long way to go to meet its potential, but this is an opportunity, not a disaster.


Share this: